Biased receptor signaling in drug discovery

T Kenakin - Pharmacological reviews, 2019 - ASPET
A great deal of experimental evidence suggests that ligands can stabilize different receptor
active states that go on to interact with cellular signaling proteins to form a range of different …

Making sense of pharmacology: inverse agonism and functional selectivity

KA Berg, WP Clarke - International Journal of …, 2018 - academic.oup.com
Constitutive receptor activity/inverse agonism and functional selectivity/biased agonism are
2 concepts in contemporary pharmacology that have major implications for the use of drugs …

Biased ligands of G protein-coupled receptors (GPCRs): Structure–functional selectivity relationships (SFSRs) and therapeutic potential

L Tan, W Yan, JD McCorvy, J Cheng - Journal of medicinal …, 2018 - ACS Publications
G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-
protein-independent pathways, and β-arrestin recruitment is the most recognized one of the …

Designing drugs and chemical probes with the dualsteric approach

J Zha, J He, C Wu, M Zhang, X Liu… - Chemical Society Reviews, 2023 - pubs.rsc.org
Traditionally, drugs are monovalent, targeting only one site on the protein surface. This
includes orthosteric and allosteric drugs, which bind the protein at orthosteric and allosteric …

G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery

M Zhang, T Chen, X Lu, X Lan, Z Chen… - Signal Transduction and …, 2024 - nature.com
G protein-coupled receptors (GPCRs), the largest family of human membrane proteins and
an important class of drug targets, play a role in maintaining numerous physiological …

2016 Philip S. Portoghese medicinal chemistry lectureship: designing bivalent or bitopic molecules for G-protein coupled receptors. The whole is greater than the sum …

AH Newman, FO Battiti, A Bonifazi - Journal of medicinal chemistry, 2019 - ACS Publications
The genesis of designing bivalent or bitopic molecules that engender unique
pharmacological properties began with Portoghese's work directed toward opioid receptors …

Biased agonism at adenosine receptors

SM McNeill, JA Baltos, PJ White, LT May - Cellular Signalling, 2021 - Elsevier
Adenosine modulates many aspects of human physiology and pathophysiology through
binding to the adenosine family of G protein-coupled receptors, which are comprised of four …

Bias translation: The final frontier?

T Kenakin - British Journal of Pharmacology, 2024 - Wiley Online Library
Biased signalling is a natural result of GPCR allosteric function and should be expected from
any and all synthetic and natural agonists. Therefore, it may be encountered in all agonist …

Importance of protein dynamics in the structure-based drug discovery of class AG protein-coupled receptors (GPCRs)

Y Lee, R Lazim, SJY Macalino, S Choi - Current opinion in structural …, 2019 - Elsevier
Highlights•GPCRs, a superfamily of membrane proteins, are vital for multiple signaling
pathways related to human physiology.•GPCR activation induces conformational changes …

Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression

MJ Wall, E Hill, R Huckstepp, K Barkan… - Nature …, 2022 - nature.com
The development of therapeutic agonists for G protein-coupled receptors (GPCRs) is
hampered by the propensity of GPCRs to couple to multiple intracellular signalling …